Seven-year follow-up of a randomized clinical trial comparing proton-pump inhibition with surgical therapy for reflux oesophagitis
British journal of surgery2007Vol. 94(2), pp. 198–203
Citations Over TimeTop 1% of 2007 papers
Lars Lundell, Pekka Miettinen, H. E. Myrvold, Jan Gunnar Hatlebakk, L. Wallin, Anna Malm, Ian Sutherland, A. Walan
Abstract
Chronic GORD can be treated effectively by either antireflux surgery or omeprazole therapy. After 7 years, surgery was more effective in controlling overall disease symptoms, but specific post-fundoplication complaints remained a problem. There appeared to be no dose escalation of omeprazole with time.
Related Papers
- → The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism(1994)42 cited
- → Esomeprazole — enhanced bio‐availability, specificity for the proton pump and inhibition of acid secretion(2003)66 cited
- → Omeprazole and clopidogrel: Should clinicians be worried?(2010)35 cited
- → Prediction of Therapeutic Doses Based on the Pharmacokinetic/Pharmacodynamic Model of Omeprazole, a Proton Pump Inhibitor.(1992)3 cited
- → Esomeprazole in the Framework of Proton‐Pump Inhibitor Development(2006)16 cited